244 related articles for article (PubMed ID: 30428735)
21. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T
Yang S; Kong F; Hou R; Rong F; Ma N; Li S; Yang J
Br J Radiol; 2017 May; 90(1073):20160760. PubMed ID: 28256923
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing MR changes associated with sacral injury after high-intensity focused ultrasound ablation of uterine fibroids.
Cun JP; Fan HJ; Zhao W; Yi GF; Jiang YN; Xie XC
Int J Hyperthermia; 2019; 36(1):21-28. PubMed ID: 30428744
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing magnetic resonance imaging finding of endopelvic fascial edema after ultrasound-guided high-intensity focused ultrasound ablation of uterine fibroids.
Liu Y; Liu Y; Lv F; Zhong Y; Xiao Z; Lv F
Int J Hyperthermia; 2022; 39(1):1088-1096. PubMed ID: 35995432
[TBL] [Abstract][Full Text] [Related]
24. Volumetric MR-HIFU ablation of uterine fibroids: role of treatment cell size in the improvement of energy efficiency.
Kim YS; Keserci B; Partanen A; Rhim H; Lim HK; Park MJ; Köhler MO
Eur J Radiol; 2012 Nov; 81(11):3652-9. PubMed ID: 21959213
[TBL] [Abstract][Full Text] [Related]
25. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data.
Łoziński T; Filipowska J; Gurynowicz G; Zgliczyńska M; Kluz T; Jędra R; Skowyra A; Ciebiera M
Int J Hyperthermia; 2019; 36(1):582-590. PubMed ID: 31159642
[No Abstract] [Full Text] [Related]
26. Occurrence of adverse events after magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) therapy in symptomatic uterine fibroids-a retrospective case-control study.
Kociuba J; Łoziński T; Zgliczyńska M; Byrczak M; Dymon M; Ciebiera M
Int J Hyperthermia; 2023; 40(1):2219436. PubMed ID: 37277102
[TBL] [Abstract][Full Text] [Related]
27. Oxytocin and Misoprostol With Diclofenac in the Preparation for Magnetic Resonance-Guided High-Intensity Ultrasound Treatment of Symptomatic Uterine Fibroids: A Prospective Cohort Study.
Łoziński T; Ludwin A; Filipowska J; Zgliczyńska M; Węgrzyn P; Kluz T; Ciebiera M
Ultrasound Med Biol; 2021 Jun; 47(6):1573-1585. PubMed ID: 33785226
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of image indexes of B-mode and power Doppler sonography on the efficacy of high intensity focused ultrasound ablation for uterine fibroids.
Chen X; Huang G; Zhang L; Bai J
Int J Hyperthermia; 2022; 39(1):772-779. PubMed ID: 35654459
[TBL] [Abstract][Full Text] [Related]
29. MRI evaluation of endopelvic fascial swelling and analysis of influencing factors in patients with uterine fibroids after high-intensity focused ultrasound ablation.
Zhang YJ; Xiao ZB; Lv FR; Sheng B; Li J; Zheng YN; Lv FJ; Chen JY
Int J Hyperthermia; 2020; 37(1):175-181. PubMed ID: 32031430
[No Abstract] [Full Text] [Related]
30. High intensity focused ultrasound treatment of adenomyosis: The relationship between the features of magnetic resonance imaging on T2 weighted images and the therapeutic efficacy.
Gong C; Setzen R; Liu Z; Liu Y; Xie B; Aili A; Zhang L
Eur J Radiol; 2017 Apr; 89():117-122. PubMed ID: 28267526
[TBL] [Abstract][Full Text] [Related]
31. Age-stratified risk factors of re-intervention for uterine fibroids treated with high-intensity focused ultrasound.
Tang NH; Fang CL; Hu WH; Tian L; Lin C; Hu HQ; Shi QL; Xu F
Int J Gynaecol Obstet; 2024 Mar; 164(3):1212-1219. PubMed ID: 37953647
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing USgHIFU ablation for adenomyosis with NPVR ≥ 50.
Yu JW; Yang MJ; Jiang L; Su XY; Chen JY
Int J Hyperthermia; 2023; 40(1):2211753. PubMed ID: 37211351
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging T2WI hyperintense foci number and the prognosis of adenomyosis after high-intensity focused ultrasound treatment.
Du CC; Wang YQ; Qu DC; Jiang LP; Yu X; Zhou HG
Int J Gynaecol Obstet; 2021 Aug; 154(2):241-247. PubMed ID: 33421123
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a radiomics model based on T2-weighted imaging for predicting the efficacy of high intensity focused ultrasound ablation in uterine fibroids.
Cheng Y; Yang L; Wang Y; Kuang L; Pan X; Chen L; Cao X; Xu Y
Quant Imaging Med Surg; 2024 Feb; 14(2):1803-1819. PubMed ID: 38415139
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience.
Cheung VYT; Lam TPW; Jenkins CR; Lam SW; Cheung GKI; Chan SSY; Choi WK
J Obstet Gynaecol; 2019 Aug; 39(6):833-839. PubMed ID: 31006301
[TBL] [Abstract][Full Text] [Related]
36. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation.
Kim YS; Lee JW; Choi CH; Kim BG; Bae DS; Rhim H; Lim HK
Radiology; 2016 Mar; 278(3):925-35. PubMed ID: 26313526
[TBL] [Abstract][Full Text] [Related]
37. Tolerance and efficacy of HIFU ablation for uterine fibroids NPVR ≥ 90%: a nested case-control study.
Gong X; Liu D; Yang MJ; Zhang R; Chen WZ; Chen JY
Int J Hyperthermia; 2022; 39(1):946-951. PubMed ID: 35853723
[TBL] [Abstract][Full Text] [Related]
38. Uterine fibroids: Influence of "T2-Rim sign" on immediate therapeutic responses to magnetic resonance imaging-guided high-intensity focused ultrasound ablation.
Yeo SY; Kim YS; Lim HK; Rhim H; Jung SH; Hwang NY
Eur J Radiol; 2017 Dec; 97():21-30. PubMed ID: 29153363
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with thermal injury of abdominal skin in focused ultrasound ablation of uterine fibroids.
Chendian T; Guohua H; Wang Z; Fang L; Luo S; Liu X; Shi Q
Int J Hyperthermia; 2024; 41(1):2295232. PubMed ID: 38159557
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: Do we need the microbubbles?
Orsi F; Monfardini L; Bonomo G; Krokidis M; Della Vigna P; Disalvatore D
Int J Hyperthermia; 2015 May; 31(3):233-9. PubMed ID: 25758436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
